Search This Blog

Thursday, May 29, 2014

CDC Vaccines for Children (VFC) Coordinators List Update

May 29, 2014



CDC Vaccines for Children (VFC) Coordinators List Update

Measles Cases in U.S. Spike to Highest Level in 20 Years - NBC News.com

Measles infections in the United States have soared to the highest level in two decades, with nearly 300 cases so far this year — and still climbing, federal health officials said Thursday.



Measles Cases in U.S. Spike to Highest Level in 20 Years - NBC News.com

Monday, May 26, 2014

Hepatitis A Exposure at Red Robin in Springfield, Missouri | Food Poisoning Bulletin

The Springfield-Greene County Health Department is alerting the public about a possible hepatitis A exposure at the Red Robin restaurant at 3720 S. Glenstone Avenue in  Springfield, Missouri. An individual recently diagnosed with the disease worked there while he or she may have been contagious. Officials fear that 5,000 people may have been exposed to the virus.



Hepatitis A Exposure at Red Robin in Springfield, Missouri | Food Poisoning Bulletin

Wednesday, May 21, 2014

CDC: Start Talking. Stop HIV.: Own Devices - YouTube

Video (0:31)



CDC: Start Talking. Stop HIV.: Own Devices - YouTube

CDC: Start Talking. Stop HIV.: Conversations - YouTube

Video (5:07)



CDC: Start Talking. Stop HIV.: Conversations - YouTube

CDC: Start Talking. Stop HIV.: Walk the Talk - YouTube

Video (0:31)



CDC: Start Talking. Stop HIV.: Walk the Talk - YouTube

CDC: Start Talking. Stop HIV.: Never Stop - YouTube

Video (0:31)



CDC: Start Talking. Stop HIV.: Never Stop - YouTube

CDC: Start Talking. Stop HIV.: Over Coffee - YouTube

Video (0:31)



CDC: Start Talking. Stop HIV.: Over Coffee - YouTube

CDC: Start Talking. Stop HIV.: Steamy Chat - YouTube

Video (0:31)



CDC: Start Talking. Stop HIV.: Steamy Chat - YouTube

Gilead’s Investigational GS-5806 Reduces Viral Load and Clinical Symptoms in Phase 2 Respiratory Syncytial Virus (RSV) Challenge Study in Adults | Gilead

SAN DIEGO--(BUSINESS WIRE)--May 20, 2014-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a placebo-controlled, Phase 2a challenge study in healthy adult patients intranasally infected with respiratory syncytial virus (RSV). The study of GS-5806, an investigational oral RSV fusion inhibitor, achieved its primary and secondary endpoints of lower viral load (the amount of virus detected in the nasal wash), improvements in total mucus weight (the amount of mucus produced by the nose) and also symptom diary score compared to placebo. Detailed results from this study (Poster #1008) will be presented today during a poster discussion session at the American Thoracic Society 2014 International Conference in San Diego.
RSV is a pathogen that infects the human respiratory tract, potentially leading to bronchiolitis and pneumonia. While most otherwise healthy people recover from the virus, there is an increased risk of severe disease and death in premature infants, individuals with certain pulmonary diseases, the elderly and those who are immune suppressed. Globally, the clinical burden of RSV infection is comparable to that of influenza.


Gilead’s Investigational GS-5806 Reduces Viral Load and Clinical Symptoms in Phase 2 Respiratory Syncytial Virus (RSV) Challenge Study in Adults | Gilead

Monday, May 19, 2014

Officials: 1.8M pounds of ground beef recalled - KAIT-Jonesboro, AR-News, weather, sports

DETROIT (AP) - Officials say a Detroit-based business is recalling about 1.8 million pounds of ground beef products sold for restaurant use in four states that may be contaminated with the bacteria E. coli.



Officials: 1.8M pounds of ground beef recalled - KAIT-Jonesboro, AR-News, weather, sports

Sunday, May 18, 2014

CDC reopens SARS playbook | TheHill

The Centers for Disease Control is using its playbook from the 2003 SARS virus scare to handle a new pandemic that has killed 173 people in the Middle East.
SARS, the severe acute respiratory syndrome, killed 774 people, but the new Middle Ease Respiratory Syndrome (MERS) is seen as even more dangerous because it has killed one in three people who have come into contact with it, compared to one in 10 for the 2003 virus.


Read more: http://thehill.com/policy/healthcare/206375-how-the-centers-for-disease-control-is-preventing-pandemic-from-spreading#ixzz326TXwYlX
Follow us: @thehill on Twitter | TheHill on Facebook




CDC reopens SARS playbook | TheHill

CDC: First case of MERS infection transmitted inside the U.S. - CNN.com

Atlanta (CNN) -- The first case of Middle East Respiratory Syndrome believed to be transmitted within the United States has been identified in an Illinois man who was infected and is no longer sick, a doctor with the Centers for Disease Control and Prevention said Saturday.



CDC: First case of MERS infection transmitted inside the U.S. - CNN.com

OLYSIO™ (simeprevir) receives marketing authorisation in the European Union for the treatment of adults with hepatitis C genotype 1 and 4 infection | Johnson & Johnson

Simeprevir provides a new triple therapy treatment option, as well as the first ever 12-week interferon-free and ribavirin independent treatment regimen, in combination with sofosbuvir, for appropriate patients in Europe



OLYSIO™ (simeprevir) receives marketing authorisation in the European Union for the treatment of adults with hepatitis C genotype 1 and 4 infection | Johnson & Johnson

Friday, May 16, 2014

Ugh - How Germs Spread in Offices and How to Stop Them in Their Tracks

Germs are expensive. Up to 40% of lost work time each year is due to the common cold per one estimate.
Offices are prime places for germs to spread — and it’s not just in the restrooms. Items we touch every day can have alarmingly high levels of bacteria and viruses. Then we carry those germs home to our families.


Ugh - How Germs Spread in Offices and How to Stop Them in Their Tracks

Wednesday, May 14, 2014

CDC HIV PrEP Guidelines: What are the Key Points? - YouTube

Video (0:42)



CDC HIV PrEP Guidelines: What are the Key Points? - YouTube

All in the Rotation « Berkeley Lab News Center

Viruses are the enigma of the biological world – despite having their own DNA and being able to adapt to their environment and evolve, they are not considered to be alive like cells. In order to reproduce and multiply – a requirement of “life” – a virus must invade a living cell, eject its DNA into that of the cell, and commandeer the cell’s biological machinery. While a virus, essentially, may be nothing more than a dollop of DNA packed into a protective coating of protein called a capsid, the packaging of that DNA is critical. The molecular motors that drive this DNA packaging process, however, have remained almost as enigmatic as the viruses themselves. A better understanding of these motors could be crucial to combating viral infections.



All in the Rotation « Berkeley Lab News Center

New insight on HIV life cycle gained through creative use of high-energy X-rays | Argonne National Laboratory

Argonne, Ill. – A key step in the decades-long mystery of the HIV life cycle was uncovered using what formerly was thought of as only a supplementary X-ray technique for structural biology. This advances study of HIV as well as highlights a powerful tool to obtain currently unobtainable high-resolution structural determination and characterization of RNA molecules.
Scientists discovered how the HIV virus recognizes its own messenger RNA amidst the more abundant collection of host cell RNA in order to pass on and replicate the genetic code for the virus. The structural basis for this export has been a mystery for more than 25 years. The use of small-angle X-ray scattering (SAXS) technique, a solution-based method that does not require protein crystallization and has minimal size limitations, succeed where traditional X-ray techniques have failed.


New insight on HIV life cycle gained through creative use of high-energy X-rays | Argonne National Laboratory

MERS outbreak becomes more urgent, WHO says - CNN.com

(CNN) -- The spread of the potentially fatal Middle East respiratory syndrome has become more serious and urgent, the World Health Organization said Wednesday.



At the same time, WHO said that -- for now, at least -- the illness known as MERS does not constitute a global health emergency



MERS outbreak becomes more urgent, WHO says - CNN.com

Thursday, May 8, 2014

Keeping the Public's Trust - YouTube

This video is for everyone who is collecting or reporting NHSN. This course discusses how to ensure accountability and improving communication around public reporting as well as how to engage consumers toward infection prevention efforts through enhanced transparency.



Keeping the Public's Trust - YouTube

MRSA Bacteremia and CDI LabID Event Reporting with Case Studies (Part II) - YouTube

This video is for everyone who is collecting or reporting NHSN MDRO/CDI Surveillance. This course allows the user to accurately apply the NHSN definitions and criteria in case scenarios for MRSA Bacteremia and CDI LabID Event Reporting.



MRSA Bacteremia and CDI LabID Event Reporting with Case Studies (Part II) - YouTube

Introduction to NHSN Analysis: A Focus on Device-associated (DA) Data (Part II) - YouTube

This video is for everyone who is collecting or reporting NHSN. This course reviews how various metrics obtained from NHSN can be interepreted and used to drive prevention of HAIs.



Introduction to NHSN Analysis: A Focus on Device-associated (DA) Data (Part II) - YouTube

Surgical Site Infections (SSI) Surveillance with Case Studies (Part II). - YouTube

This video is for everyone who is collecting or reporting NHSN SSI Surveillance. This course allows the user to accurately apply the NHSN definitions and criteria in case scenarios for SSI.



Surgical Site Infections (SSI) Surveillance with Case Studies (Part II). - YouTube